Posts Tagged ‘obesity’

On this Christmas Day, we have a simple wish. It is the wish that equitable access to obesity care, free from stigma and blame, should be available to all. Right now, that is clearly not true. And there’s a lot to suggest that the trends are headed in precisely the wrong direction. Skimming the Cream […]

It is no secret that alcohol use disorder is a risk after metabolic and bariatric surgery. The risk rises as time passes after surgery, with one study finding three percent of patients followed for a median of six years having one alcohol use disorder diagnosis in their medical records. Another study found that three years […]

We strongly suspect that advanced oral obesity medicines may be a defining milestone for 2026. This is because they have the potential to fill an important gap in obesity therapy – the unmet need for therapies that people can persistently take to maintain control of this chronic disease. Late yesterday, FDA granted approval for the […]

This has been quite a year. Many remarkable changes we’ve witnessed go well beyond the scope of this commentary. In the policy realm, some of them are close at hand. CDC, which has long guided health policy on obesity, nutrition, and physical activity, has been decimated. NIH is under extraordinary stress. But on the positive […]

News from Lilly about orforglipron this week points to what might be the next big development for GLP-1 medicines. The company announced topline results for a weight maintenance study of orforglipron and this first glimpse has us thinking that maintain might be the magic word in obesity care next year. The topline come from the […]

For addressing diet-related diseases – especially obesity – a great deal of attention goes toward the demand for food in comparison to the supply. Think about all the effort that goes into nudging people toward healthier diets. Nutrition Facts labels insinuate what is “healthy” to eat and what is not. We have epic battles about […]

The unmet need for delivering obesity care at scale is indisputably great. Just thinking about it is daunting because the need is so great. It will require new thinking. One thread of that new thinking is all of the innovation in telemedicine that’s unfolding before our eyes. In Obesity this month, we see yet another […]

Business is apparently booming in the criminal trade for bogus obesity medicines. The Times (London) reports that criminals are selling dangerous weight-loss jabs on social media and in gyms. They write that: “Pharmaceutical bosses have issued a stark warning about medicines such as Mounjaro sold online without safety controls as gangs branch out from hard […]

Truveta this week published data that reveals striking growth in the use of GLP-1s by women with PCOS (polycystic ovary syndrome). Prescriptions for semaglutide or tirzepatide have risen by more than 700% in women with PCOS, according to their analysis. So don’t think that this is slipping right by the bean counters at drug benefit […]

The International Journal of Obesity has published a map for future directions in weight bias research. The quality and global diversity of thinking that went into the summit which produced this roadmap is exceptional. The source of this thinking was the International Weight Bias Summit last year in Montreal at Concordia University. Support for the […]